Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
XENE
#1340
Xenon Pharmaceuticals Inc
58.880
0
USD
-0.79%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-0.79%
Aylık Değişim
+6.94%
6 aylık değişim
+44.35%
Yıllık Değişim
+44.35%
Önceki Kapanış
59.350
0
Open
58.880
0
Bid
Ask
Low
58.880
0
High
58.880
0
Hacim
62
Piyasalar
ABD Borsası
Sağlık Hizmetleri
XENE
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
76.54 M
76.73 M
77.11 M
77.28 M
83.19 M
—
Valuation ratios
Enterprise value
2.86 B
2.46 B
2.28 B
3 B
3.53 B
11.26 B
Price to earnings ratio
-13.02
-10.42
-8.84
-10.35
-10.28
-39.89
Price to sales ratio
-2 869.8
421.96
394.3
525.94
473.62
1 815.83
Price to cash flow ratio
-16.83
-13.41
-10.67
-12.54
-12.73
-49.36
Price to book ratio
4.04
0.84
0.85
1.19
6.11
8.99
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.08
-0.09
-0.13
-0.15
-0.17
-0.53
Return on equity %
-0.09
-0.09
-0.13
-0.16
-0.18
-0.57
Return on invested capital %
-171.26
-170.59
-211.02
-254.85
-434.29
-1 070.74
Gross margin %
100
100
—
—
—
—
Operating margin %
5 242.02
-969.84
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
4 444.18
-867.29
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
17.85
17.66
15.14
12.52
13.42
58.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0
0.01
0
0
0
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.7
-0.78
-0.81
-0.91
-1.03
-3.53
EBIT per share
-1.01
-0.92
-1.19
-1.22
-1.39
-4.72
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
8.05
6.98
6.18
5.83
6.93
25.92
Net current asset value per share
8.16
7.19
6.34
6.06
7.07
26.66
Tangible book value per share
9.69
8.95
8.03
7.06
7.34
31.38
Working capital per share
7.7
6.78
5.92
5.57
6.55
24.82
Book value per share
9.69
8.95
8.03
7.06
7.34
31.38
Haberler
Xenon Pharmaceuticals AAN’de azetukalner epilepsi verilerini sunacak
Xenon Pharmaceuticals Stock Soars 20% in 3 Months: Here's Why
Wedbush, Xenon Pharmaceuticals hisse hedefini 63 dolara düşürdü
Wedbush lowers Xenon Pharmaceuticals stock price target to $63
BofA, Xenon Pharmaceuticals için hedef fiyatı yükseltti
BofA raises Xenon Pharmaceuticals price target on trial success
Xenon Pharmaceuticals closes $747.5M public offering
Xenon Pharmaceuticals 650 milyon dolarlık halka arzı fiyatladı
Xenon Pharmaceuticals prices $650M public offering at $57/share
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
Citizens, Rapport Therapeutics hissesi için hedef fiyatı korudu
Citizens reiterates Rapport Therapeutics stock rating on seizure drug potential